Chang Irene J, Hahn Si Houn
Division of Medical Genetics, Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA.
Division of Genetic Medicine, Department of Pediatrics, University of Washington School of Medicine, Seattle Children's Hospital, Seattle, WA, USA.
Handb Clin Neurol. 2017;142:19-34. doi: 10.1016/B978-0-444-63625-6.00003-3.
Wilson disease (WD) is an autosomal-recessive disorder of hepatocellular copper deposition caused by pathogenic variants in the copper-transporting gene, ATP7B. Early detection and treatment are critical to prevent lifelong neuropsychiatric, hepatic, and systemic disabilities. Due to the marked heterogeneity in age of onset and clinical presentation, the diagnosis of Wilson disease remains challenging to physicians today. Direct sequencing of the ATP7B gene is the most sensitive and widely used confirmatory testing method, and concurrent biochemical testing improves diagnostic accuracy. More than 600 pathogenic variants in ATP7B have been identified, with single-nucleotide missense and nonsense mutations being the most common, followed by insertions/deletions, and, rarely, splice site mutations. The prevalence of Wilson disease varies by geographic region, with higher frequency of certain mutations occurring in specific ethnic groups. Wilson disease has poor genotype-phenotype correlation, although a few possible modifiers have been proposed. Improving molecular genetic studies continue to advance our understanding of the pathogenesis, diagnosis, and screening for Wilson disease.
威尔逊病(WD)是一种常染色体隐性疾病,由铜转运基因ATP7B的致病变异导致肝细胞铜沉积。早期检测和治疗对于预防终身神经精神、肝脏和全身残疾至关重要。由于发病年龄和临床表现存在显著异质性,如今威尔逊病的诊断对医生来说仍然具有挑战性。ATP7B基因的直接测序是最敏感且应用最广泛的确诊检测方法,同时进行生化检测可提高诊断准确性。已鉴定出ATP7B基因中的600多个致病变异,单核苷酸错义突变和无义突变最为常见,其次是插入/缺失,很少见剪接位点突变。威尔逊病的患病率因地理区域而异,特定种族群体中某些突变的发生频率较高。尽管已提出一些可能的修饰因子,但威尔逊病的基因型与表型相关性较差。不断改进的分子遗传学研究继续推动我们对威尔逊病发病机制、诊断和筛查的理解。